NASDAQ · JBIO
Jade Biosciences, Inc.
$14.02-$0.22 (-1.52%)
Jade Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.92% below the high.
Loading market information…
NASDAQ · BLI · USD
Stock price, earnings
Quote as of Mar 21, 2023, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Berkeley Lights, Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Berkeley Lights, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products. The company provides a unified technology platform, which encompasses proprietary consumables such as OptoSelect chips and specialized reagent kits, sophisticated automation systems, and purpose-built application and workflow software. BLI extends its services to clients across North America, the Asia Pacific region, and Europe. Founded in 2011, its corporate headquarters are located in Emeryville, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:34 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2021 |
|---|
| Feb 24, 2022 |
| -$0.26+7.14% vs estimate |
| $23.19M-18.19% vs estimate |
| Q3 2021 | Nov 4, 2021 | -$0.30-25.0% vs estimate | $24.32M+4.31% vs estimate |
|---|
THE ANALYST VIEW
9 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$14.02-$0.22 (-1.52%)
Jade Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.92% below the high.
$2.09-$0.01 (-0.48%)
HilleVax, Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.69% below the high.
$1.88$0.00 (0.0%)
Jounce Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.99% below the high.
$2.97-$0.21 (-6.6%)
Insight Molecular Diagnostics Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.63% below the high.
$2.05-$0.05 (-2.38%)
Aadi Bioscience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.22% below the high.
$3.39+$0.02 (+0.59%)
Miromatrix Medical Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.07% below the high.
$1.27$0.00 (0.0%)
IGM Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.36% below the high.
$1.07-$0.01 (-0.93%)
Surface Oncology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.17% below the high.
